View Cart

Men’s Health

Required Reading on GLPs: Ashley Koff’s “Your Best Shot”

By Robert Bonakdar, MD, Contributing Writer

GLP-1–based therapies, including glucagon-like peptide-1 receptor agonists (e.g., semaglutide), dual incretin agonists (e.g. tirzepatide), and forthcoming GLP-1–modulating drugs like retatrutide, have rapidly reshaped the clinical management of obesity, type 2 diabetes, and cardiometabolic disease. In less than a decade, these drugs have moved from the weight management and endocrinology niches to much wider use in […]

Read more ...

Is Male Infertility Contributing to Falling Birth Rates?

By Joshua Cohen

(This article was originally published on Dec. 3, 2025 on Undark.) For decades, U.S. marriage rates have been on the decline while the average age at which Americans have children has risen. Alongside this, birth rates have dropped — a phenomenon the Health and Human Services Secretary Robert F. Kennedy, Jr. has called a “national […]

Read more ...

Beacons Through the (Brain) Fog: Corey Schuler on Holistic Approaches to Cognitive Dysfunction

By Erik Goldman, Editor in Chief

Assessing and treating cognitive dysfunction is a challenge. The problems can show up in myriad ways, with multiple potential causes. Cognitive impairment is often connected with, and reflective of, disease and dysfunction in other organ systems. Though surveys consistently show that many people worry about developing dementia, individual patients may not always be forthright about […]

Read more ...

NSCC Conference Preview: The Science & Practice of Healthy Aging

By Robert Bonakdar, MD

There are numerous claims about what supports longevity and healthspan, and it can be difficult to discern what is real from what is hype in this overheated field. That is why we’ve made The Science and Practice of Healthy Aging the theme of the 2nd annual Nutrition & Supplementation in Clinical Care (NSCC) Conference, which […]

Read more ...

Rethinking Alzheimer’s: The Role of Microglial Cells Is Key

By Erik Goldman

For decades, Alzheimer’s disease research, and the clinical approaches that derive from it, have been hyper-focused on amyloid-β and its deleterious effects. But despite billions spent, this line of work has yet to yield a single truly effective drug therapy. That’s because there’s far more to the Alzheimer’s equation than amyloid plaques. In fact, by […]

Read more ...

To Help Patients Sleep, Ask the Right Questions

By Ron Grisanti, DC, Contributing Writer

Conventional medicine tends to view insomnia as an isolated problem — a nuisance symptom to be ameliorated. The solutions offered usually fall into three categories: Basic sleep hygiene advice: Recommendations like reducing screen time, keeping the bedroom dark, or sticking to a bedtime routine are helpful, but they are rarely enough on their own. For […]

Read more ...

Noise: Not Just a Nuisance, It’s a Public Health Risk

By Erik Goldman

Back at the turn of the 20th Century, physician-bacteriologist Robert Koch predicted that, “One day, man will have to fight noise as fiercely as cholera and the plague.” That day is definitely upon us. The detrimental impact of noise goes far beyond the obvious problem of hearing loss. Over the last decades, researchers have shown, […]

Read more ...

Meds Review a Must for People with Osteoporosis

By John Neustadt, ND, Contributing Writer

Up to 30% of osteoporosis cases in postmenopausal women are caused by external factors like medications, rather than simply the decrease in estrogen that occurs around menopause. That’s according to a Mayo Clinic report from more than 20 years ago. In pre-menopausal women and men, that number is up around an astonishing 50%. Those are […]

Read more ...

Are Weight-Loss Drugs Contributing to a Fall in the Obesity Rate?

By Joshua Cohen

(This article was originally published by Undark.org on Dec. 9, 2024, and republished here with permission) Earlier this fall, the Centers for Disease Control and Prevention reported data showing that adult obesity rates — long trending upwards — had fallen modestly over the past few years, from 41.9 to 40.3 percent. The decline sparked discussion […]

Read more ...

Folic Acid: Too Much of a Good Thing?

By Gil Winkelman, ND, Contributing Writer

It is time to rethink how we’re using folate, and its derivatives, methylfolate and folinic acid. Recent research suggests that people who routinely take more than 1000 μg of folic acid per day may be at increased risk of cognitive decline, asthma, impaired immune function, and certain types of cancer (Fardous AM, et al. Nutrients. […]

Read more ...

Copyright © 2026 Holistic Primary Care. All Rights Reserved.